ProDa BioTech L.L.C.
Marietta, GA · Biotech · Private
ProAgio, a novel therapeutic protein designed to target integrin αvβ3 and induce apoptosis of cancer-associated pancreatic stellate cells and angiogenic endothelial cells
- Grants
- $6.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a protein drug for pancreatic cancer treatment | $167,021 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a protein drug for pancreatic cancer treatment | $1,999,560 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a protein drug for pancreatic cancer treatment | $2,478,350 | |
| Federal grant | Department of Health and Human Services · Phase II · A treatment drug for triple negative breast cancer | $1,999,124 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2248 | NAPROGENIX, INC. | — | — |
| 2249 | BRIDGENE BIOSCIENCES, INC. | — | — |
| 2250 | OpalGenix, Inc. | — | — |
| 2251 | ProDa BioTech L.L.C. | — | — |
| 2252 | AUMENTA BIOSCIENCES, INC. | — | — |
| 2253 | General Reasoning, Inc. | — | $11M |
| 2254 | ADDUCTNE LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Treating Fibrosis Using PKM2 Activatorsapplication
- Methods For Treating Fibrosis Using PKM2 Activatorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.